The items, which are deemed to be of relatively low clinical effectiveness, to have cheaper options available or to be of "low priority" for funding, are:
1) Amiodarone - to treat abnormal heart rhythms
2) Dronedarone - to treat the heart condition atrial fibrillation
I think there are a lot of people here that will be affected by this. I think its a sense of things to come.
Thoughts people???